AcelRx Pharmaceuticals Inc (ACRX) Insider Trading

Total insider buys:
  • $24,569,282.47
Total insider sells:
  • $22,656,957.06
Most recent insider trade:
  • June 7, 2022
Most active insider trader:
  • Mark G Edwards
Trader NameDateTitleAmountPriceTypeTotal Value
June 7, 2022CEO46,400$0.22Buy$10,208.00
June 15, 2020Director100,000$1.33Buy$133,000.00
June 15, 2020CEO7,547$1.33Buy$10,037.51
Nov. 12, 2019Director25,000$1.78Buy$44,500.00
Nov. 11, 2019CEO8,379$1.79Buy$14,998.41
Aug. 26, 2019Director15,000$2.19Buy$32,850.00
Aug. 23, 2019Director10,000$2.20Buy$22,000.00
June 5, 2019CEO5,000$2.31Buy$11,550.00
March 12, 2019Director19,000$2.99Buy$56,810.00
Feb. 28, 2019Insider840$2.81Buy$2,360.40
Feb. 28, 2019CFO3,647$2.81Buy$10,248.07
Feb. 28, 2019CEO3,234$2.81Buy$9,087.54
Dec. 14, 2018CFO5,000$2.78Buy$13,900.00
Dec. 14, 2018CEO3,610$2.78Buy$10,035.80
Dec. 12, 2018CEO10,000$2.99Buy$29,900.00
Nov. 19, 2018Insider16,000$3.07Buy$49,120.00
Nov. 15, 2018Director20,700$2.82Buy$58,374.00
Nov. 13, 2018CFO5,000$3.13Buy$15,650.00
Oct. 15, 2018Insider28,351$5.00Sell$141,755.00
Sept. 24, 2018Insider6,953$4.50Sell$31,288.50
Aug. 7, 2018Director5,300$2.84Buy$15,052.00
Aug. 7, 2018CEO10,000$2.90Buy$29,000.00
Aug. 6, 2018Insider37,000$2.75Buy$101,750.00
Aug. 6, 2018CFO5,000$2.75Buy$13,750.00
June 5, 2018Director5,000$3.35Buy$16,750.00
June 1, 2018Director300$3.30Buy$990.00
May 25, 2018CFO5,000$3.18Buy$15,900.00
Nov. 14, 2017Director30,000$1.90Buy$57,000.00
Nov. 13, 2017CFO5,000$1.94Buy$9,700.00
Oct. 2, 2017Insider10,161$5.29Sell$53,751.69
Sept. 11, 2017CFO7,000$3.24Buy$22,680.00
Aug. 24, 2017Director5,000$3.02Buy$15,100.00
Aug. 24, 2017CEO15,000$3.00Buy$45,000.00
Aug. 22, 2017Insider10,000$2.95Buy$29,500.00
June 19, 2017Major Shareholder875,000$2.40Sell$2,100,000.00
Sept. 29, 2016Major Shareholder216,500$3.92Sell$848,680.00
Sept. 15, 2016Major Shareholder392,850$3.70Sell$1,453,545.00
May 13, 2016CEO10,206$3.26Buy$33,271.56
May 12, 2016Director15,000$3.15Buy$47,250.00
Nov. 18, 2015Major Shareholder176,200$5.35Sell$942,670.00
Nov. 6, 2015Major Shareholder92,100$4.59Sell$422,739.00
Sept. 9, 2015Major Shareholder310,000$4.18Sell$1,295,800.00
May 7, 2015Director40,000$3.13Buy$125,200.00
March 10, 2014Director1,000,000$12.35Sell$12,350,000.00
Nov. 7, 2013major shareholder200,000$6.51Buy$1,302,000.00
Nov. 4, 2013major shareholder155,000$6.87Buy$1,064,850.00
Nov. 1, 2013Major Shareholder360,660$6.91Buy$2,492,160.60
Sept. 20, 2013Director158,153$10.59Sell$1,674,840.27
Sept. 18, 2013Director128,780$10.42Sell$1,341,887.60
July 23, 2013Major Shareholder850,000$11.65Buy$9,902,500.00
First«1 of 2»Last
  • Insiders are both buying and selling AcelRx Pharmaceuticals Inc stock.

  • The insider traders at AcelRx Pharmaceuticals Inc are: Mark G Edwards, Perceptive Advisors Llc, Vincent J Angotti, Raffi Asadorian, Vincent J. Angotti, Guy Nohra, Lawrence G Hamel, Pamela P Palmer, Pamela P. Palmer, Adrian Adams, Badri N Dasu, Life Sciences Maste Perceptive, Mark A Wan, Mark Wan, and Howard B Rosen

  • The most active insider trader at AcelRx Pharmaceuticals Inc is Mark G Edwards with 13 trades.

  • Mark Wan has sold the most AcelRx Pharmaceuticals Inc stock with a total value of $24,700,000.00.

  • Perceptive Advisors Llc has bought the most AcelRx Pharmaceuticals Inc stock with a total value of $16,063,510.60.

  • The most recent insider trade for AcelRx Pharmaceuticals Inc was on June 7, 2022.

  • The single biggest insider buy for AcelRx Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $9,902,500.00 on July 23, 2013.

  • The single biggest insider sell for AcelRx Pharmaceuticals Inc was from Mark Wan with a total value of $12,350,000.00 on March 10, 2014.